240 related articles for article (PubMed ID: 32697931)
1. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
Dragonetti D; Guarini G; Pizzuti M
Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
[No Abstract] [Full Text] [Related]
2. Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease.
Lozano R; Franco ME
Med Clin (Barc); 2020 Nov; 155(9):409-410. PubMed ID: 32883507
[No Abstract] [Full Text] [Related]
3. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
Schulman S
Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
[No Abstract] [Full Text] [Related]
4. Coagulation abnormalities and thrombosis in patients with COVID-19.
Levi M; Thachil J; Iba T; Levy JH
Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
[No Abstract] [Full Text] [Related]
5. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.
Benhamou D; Keita H; Ducloy-Bouthors AS;
Anaesth Crit Care Pain Med; 2020 Jun; 39(3):351-353. PubMed ID: 32437961
[No Abstract] [Full Text] [Related]
6. COVID-19 patient with immune thrombocytopenic purpura.
Kewan T; Almhana F; Schwartzman L; Daw H; Haddad A
Int J Lab Hematol; 2020 Dec; 42(6):e260-e262. PubMed ID: 32786138
[No Abstract] [Full Text] [Related]
7. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).
Foldes D; Hinton R; Arami S; Bain BJ
Am J Hematol; 2020 Jul; 95(7):861-862. PubMed ID: 32298486
[No Abstract] [Full Text] [Related]
9. Autoimmune heparin-induced thrombocytopenia.
Greinacher A; Selleng K; Warkentin TE
J Thromb Haemost; 2017 Nov; 15(11):2099-2114. PubMed ID: 28846826
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease.
Nowak G
Thromb Haemost; 2009 Nov; 102(5):887-91. PubMed ID: 19888524
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
[TBL] [Abstract][Full Text] [Related]
12. The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?
Mozzini C; Girelli D
Thromb Res; 2020 Jul; 191():26-27. PubMed ID: 32360977
[No Abstract] [Full Text] [Related]
13. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
Horowitz NA; Brenner B
Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
[No Abstract] [Full Text] [Related]
14. Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis.
Ahmad S; Untch B; Haas S; Hoppensteadt DA; Misselwitz F; Messmore HL; Walenga JM; Fareed J
Mol Cell Biochem; 2004 Mar; 258(1-2):163-70. PubMed ID: 15030181
[TBL] [Abstract][Full Text] [Related]
15. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
Pooni RS
Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
[No Abstract] [Full Text] [Related]
16. Venous thromboembolism and COVID-19.
Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O
Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397
[No Abstract] [Full Text] [Related]
17. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
Merli M; Ageno W; Sessa F; Salvini M; Caramazza D; Mora B; Rossi A; Rovelli C; Passamonti F; Grossi P
Ann Hematol; 2020 Aug; 99(8):1951-1952. PubMed ID: 32529284
[No Abstract] [Full Text] [Related]
18. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.
Hindilerden F; Yonal-Hindilerden I; Akar E; Kart-Yasar K
Thromb Res; 2020 Nov; 195():136-138. PubMed ID: 32688098
[No Abstract] [Full Text] [Related]
19. COVID-19 as a cause of immune thrombocytopenia.
Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
[No Abstract] [Full Text] [Related]
20. Immune-Mediated Coagulopathy in COVID-19 Infection.
Vadasz Z; Brenner B; Toubi E
Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
